Results

eNauka >  Results >  Genomic variation in the MAP3K5 gene is associated with beta-thalassemia disease severity and hydroxyurea treatment efficacy
Title: Genomic variation in the MAP3K5 gene is associated with beta-thalassemia disease severity and hydroxyurea treatment efficacy
Authors: Tafrali, Christina; Paizi, Arsinoi; Borg, Joseph; Radmilović Milena  ; Bartsakoulia, Marina; Giannopoulou, Emily; Giannakopoulou, Olga; Stojiljković, Maja  ; Zukić, Branka  ; Poulas, Konstantinos;
Issue Date: 2013
Publication: Pharmacogenomics
ISSN: 1462-2416 Pharmacogenomics Search Idenfier
Publisher: Future Medicine Ltd, London
Type: Article
Collation: vol. 14 br. 5 str. 469-483
DOI: 10.2217/pgs.13.31
WoS-ID: 000317177700012
Scopus-ID: 2-s2.0-84875936756
PMID: 23556445
URI: https://imagine.imgge.bg.ac.rs/handle/123456789/640
https://enauka.gov.rs/handle/123456789/284966
Project: long-term EMBO fellowship [ALTF 71-2011]
Research Promotion Foundation of Cyprus grant [RPFPiLambdaE046_02]
European Commission grant [FP7-200754]
'SEE-DRUG' project [FP7-REGPOT-2011-1]
Metadata source: Migracija
M-category: 
21M21

23
SCOPUSTM
8
PubMed CentralTM
21
OpenCitations
23
WEB OF SCIENCETM
Altmetric
Dimensions

Find the DOI

Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.